FREDRIC N ESHELMAN Insider Trading $PPDI PHARMACEUTICAL PRODUCT DEVELOPMENT INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for FREDRIC N ESHELMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of FREDRIC N ESHELMAN. FREDRIC N ESHELMAN is Director in Valeant Pharmaceuticals International, Inc. ($BVF) and CEO in PHARMACEUTICAL PRODUCT DEVELOPMENT INC ($PPDI) and Chief Executive Officer in PHARMACEUTICAL PRODUCT DEVELOPMENT INC ($PPDI) and Director in MEDICINES CO /DE ($MDCO) and Executive Chairman in MEDICINES CO /DE ($MDCO) and Director in Aravive, Inc. ($ARAV) and Director in G1 Therapeutics, Inc. ($GTHX) and Director in EYENOVIA, INC. ($EYEN).
FREDRIC N ESHELMAN in PHARMACEUTICAL PRODUCT DEVELOPMENT INC
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of FREDRIC N ESHELMAN: CEO, Chief Executive Officer
Holdings: 7,965,626 shares
Latest Transaction: Aug 29 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of FREDRIC N ESHELMAN in PHARMACEUTICAL PRODUCT DEVELOPMENT INC
Sentiment: All, ARAV, BVF, EYEN, GTHX, MDCO, PPDI
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 25 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.55 | 1,805 | 107,488 | 5,014,857 | 5 M to 5 M (-0.04 %) |
| Jul 25 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.35 | 6,573 | 390,108 | 5,016,662 | 5 M to 5 M (-0.13 %) |
| Jul 25 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.33 | 672 | 39,870 | 5,023,235 | 5 M to 5 M (-0.01 %) |
| Jul 25 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.29 | 2,250 | 133,403 | 5,023,907 | 5 M to 5 M (-0.04 %) |
| Jul 25 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.27 | 1,800 | 106,686 | 5,026,157 | 5 M to 5 M (-0.04 %) |
| Jul 25 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.30 | 600 | 35,580 | 5,027,957 | 5 M to 5 M (-0.01 %) |
| Jul 25 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.31 | 2,754 | 163,340 | 5,028,557 | 5 M to 5 M (-0.05 %) |
| Jul 25 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.19 | 3,255 | 192,663 | 5,031,311 | 5 M to 5 M (-0.06 %) |
| Jul 25 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.77 | 245 | 14,644 | 5,034,566 | 5 M to 5 M (0.00 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.38 | 200 | 11,876 | 5,034,811 | 5 M to 5 M (0.00 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.28 | 7,900 | 468,312 | 5,035,011 | 5 M to 5 M (-0.16 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.26 | 100 | 5,926 | 5,042,911 | 5 M to 5 M (0.00 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.58 | 100 | 5,958 | 5,043,011 | 5 M to 5 M (0.00 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.86 | 200 | 11,972 | 5,043,111 | 5 M to 5 M (0.00 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.94 | 3,264 | 195,644 | 5,043,311 | 5 M to 5 M (-0.06 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.96 | 2,400 | 143,904 | 5,046,575 | 5 M to 5 M (-0.05 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.45 | 2,128 | 126,510 | 5,048,975 | 5.1 M to 5 M (-0.04 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.70 | 3,600 | 214,920 | 5,051,103 | 5.1 M to 5.1 M (-0.07 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.31 | 46 | 2,728 | 5,054,703 | 5.1 M to 5.1 M (0.00 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.99 | 91 | 5,459 | 5,054,749 | 5.1 M to 5.1 M (0.00 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 60.11 | 760 | 45,684 | 5,054,840 | 5.1 M to 5.1 M (-0.02 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 60.14 | 100 | 6,014 | 5,055,600 | 5.1 M to 5.1 M (0.00 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 60.08 | 300 | 18,024 | 5,055,700 | 5.1 M to 5.1 M (-0.01 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 60.10 | 1,600 | 96,160 | 5,056,000 | 5.1 M to 5.1 M (-0.03 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.42 | 2,000 | 118,840 | 5,057,600 | 5.1 M to 5.1 M (-0.04 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.67 | 453 | 27,031 | 5,059,600 | 5.1 M to 5.1 M (-0.01 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Buy | S | 59.37 | 699 | 41,500 | 5,060,053 | 5.1 M to 5.1 M (+0.01 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.27 | 300 | 17,781 | 5,060,752 | 5.1 M to 5.1 M (-0.01 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.29 | 200 | 11,858 | 5,061,052 | 5.1 M to 5.1 M (0.00 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.39 | 200 | 11,878 | 5,061,252 | 5.1 M to 5.1 M (0.00 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.65 | 5,712 | 340,721 | 5,061,452 | 5.1 M to 5.1 M (-0.11 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.83 | 7,322 | 438,075 | 5,067,164 | 5.1 M to 5.1 M (-0.14 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.93 | 200 | 11,986 | 5,074,486 | 5.1 M to 5.1 M (0.00 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.95 | 2,001 | 119,960 | 5,074,686 | 5.1 M to 5.1 M (-0.04 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.91 | 1,800 | 107,838 | 5,076,687 | 5.1 M to 5.1 M (-0.04 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 60.29 | 6,900 | 416,001 | 5,078,487 | 5.1 M to 5.1 M (-0.14 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.68 | 1,700 | 101,456 | 5,085,387 | 5.1 M to 5.1 M (-0.03 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.72 | 2,800 | 167,216 | 5,087,087 | 5.1 M to 5.1 M (-0.06 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.74 | 2,700 | 161,298 | 5,089,887 | 5.1 M to 5.1 M (-0.05 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.82 | 1,418 | 84,825 | 5,092,587 | 5.1 M to 5.1 M (-0.03 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.60 | 2,540 | 151,384 | 5,094,005 | 5.1 M to 5.1 M (-0.05 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.75 | 6,851 | 409,347 | 5,096,545 | 5.1 M to 5.1 M (-0.13 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.48 | 1,964 | 116,819 | 5,103,396 | 5.1 M to 5.1 M (-0.04 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.40 | 500 | 29,700 | 5,105,360 | 5.1 M to 5.1 M (-0.01 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.50 | 5,862 | 348,789 | 5,105,860 | 5.1 M to 5.1 M (-0.11 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.64 | 2,992 | 178,443 | 5,111,722 | 5.1 M to 5.1 M (-0.06 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.62 | 840 | 50,081 | 5,114,714 | 5.1 M to 5.1 M (-0.02 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 60.05 | 5,000 | 300,250 | 5,115,554 | 5.1 M to 5.1 M (-0.10 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 60.31 | 140 | 8,443 | 5,120,554 | 5.1 M to 5.1 M (0.00 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 60.33 | 90 | 5,430 | 5,120,694 | 5.1 M to 5.1 M (0.00 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.78 | 478 | 28,575 | 5,120,784 | 5.1 M to 5.1 M (-0.01 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 60.03 | 459 | 27,554 | 5,121,262 | 5.1 M to 5.1 M (-0.01 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 60.02 | 4,000 | 240,080 | 5,121,721 | 5.1 M to 5.1 M (-0.08 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 60.06 | 7,504 | 450,690 | 5,125,721 | 5.1 M to 5.1 M (-0.15 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.84 | 5,733 | 343,063 | 5,133,225 | 5.1 M to 5.1 M (-0.11 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.85 | 3,300 | 197,505 | 5,138,958 | 5.1 M to 5.1 M (-0.06 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.81 | 4,044 | 241,872 | 5,142,258 | 5.1 M to 5.1 M (-0.08 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.79 | 1,736 | 103,795 | 5,146,302 | 5.1 M to 5.1 M (-0.03 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.73 | 3,000 | 179,190 | 5,148,038 | 5.2 M to 5.1 M (-0.06 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.55 | 200 | 11,910 | 5,151,038 | 5.2 M to 5.2 M (0.00 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.71 | 100 | 5,971 | 5,151,238 | 5.2 M to 5.2 M (0.00 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.49 | 936 | 55,683 | 5,151,338 | 5.2 M to 5.2 M (-0.02 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.52 | 5,717 | 340,276 | 5,152,274 | 5.2 M to 5.2 M (-0.11 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.51 | 3,511 | 208,940 | 5,157,991 | 5.2 M to 5.2 M (-0.07 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.97 | 6,900 | 413,793 | 5,161,502 | 5.2 M to 5.2 M (-0.13 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.53 | 4,300 | 255,979 | 5,168,402 | 5.2 M to 5.2 M (-0.08 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.63 | 8,900 | 530,707 | 5,172,702 | 5.2 M to 5.2 M (-0.17 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.61 | 8,060 | 480,457 | 5,181,602 | 5.2 M to 5.2 M (-0.16 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.59 | 3,007 | 179,187 | 5,189,662 | 5.2 M to 5.2 M (-0.06 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.76 | 11,163 | 667,101 | 5,192,669 | 5.2 M to 5.2 M (-0.21 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.80 | 5,431 | 324,774 | 5,203,832 | 5.2 M to 5.2 M (-0.10 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 60.01 | 19,900 | 1,194,199 | 5,209,263 | 5.2 M to 5.2 M (-0.38 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 60.02 | 12,851 | 771,317 | 5,229,163 | 5.2 M to 5.2 M (-0.25 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 60.25 | 600 | 36,150 | 5,242,014 | 5.2 M to 5.2 M (-0.01 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 60.21 | 9,100 | 547,911 | 5,242,614 | 5.3 M to 5.2 M (-0.17 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 60.11 | 5,541 | 333,070 | 5,251,714 | 5.3 M to 5.3 M (-0.11 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 60.07 | 400 | 24,028 | 5,257,255 | 5.3 M to 5.3 M (-0.01 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 60.17 | 4,800 | 288,816 | 5,257,655 | 5.3 M to 5.3 M (-0.09 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 60.19 | 200 | 12,038 | 5,262,455 | 5.3 M to 5.3 M (0.00 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.96 | 3,500 | 209,860 | 5,262,655 | 5.3 M to 5.3 M (-0.07 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 60.29 | 18 | 1,085 | 5,266,155 | 5.3 M to 5.3 M (0.00 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 60.15 | 7,575 | 455,636 | 5,266,173 | 5.3 M to 5.3 M (-0.14 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 60.03 | 12,389 | 743,712 | 5,273,748 | 5.3 M to 5.3 M (-0.23 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 60.00 | 35,977 | 2,158,620 | 5,286,137 | 5.3 M to 5.3 M (-0.68 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 60.08 | 505 | 30,340 | 5,322,114 | 5.3 M to 5.3 M (-0.01 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 60.10 | 159 | 9,556 | 5,322,619 | 5.3 M to 5.3 M (0.00 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 60.09 | 3,537 | 212,538 | 5,322,778 | 5.3 M to 5.3 M (-0.07 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 60.06 | 1,000 | 60,060 | 5,326,315 | 5.3 M to 5.3 M (-0.02 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 60.05 | 10,948 | 657,427 | 5,327,315 | 5.3 M to 5.3 M (-0.21 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.97 | 1,700 | 101,949 | 5,338,263 | 5.3 M to 5.3 M (-0.03 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.98 | 19,100 | 1,145,618 | 5,339,963 | 5.4 M to 5.3 M (-0.36 %) |
| Jul 22 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 59.99 | 3,200 | 191,968 | 5,359,063 | 5.4 M to 5.4 M (-0.06 %) |
| May 27 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Option Exercise | M | 29.89 | 40,000 | 1,195,600 | 205,000 | |
| May 27 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Option Exercise | M | 26.22 | 50,000 | 1,311,000 | 245,000 | |
| May 27 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Option Exercise | M | 18.63 | 70,000 | 1,303,750 | 295,000 | |
| May 27 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Option Exercise | M | 6.53 | 100,000 | 653,120 | 365,000 | |
| May 27 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Option Exercise | M | 14.00 | 60,000 | 840,000 | 465,000 | |
| May 27 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Option Exercise | M | 6.72 | 60,000 | 403,122 | 525,000 | |
| May 27 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Buy | M | 29.89 | 40,000 | 1,195,600 | 5,362,263 | 5.3 M to 5.4 M (+0.75 %) |
| May 27 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Buy | M | 26.22 | 50,000 | 1,311,000 | 5,322,263 | 5.3 M to 5.3 M (+0.95 %) |
| May 27 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Buy | M | 18.63 | 70,000 | 1,303,750 | 5,272,263 | 5.2 M to 5.3 M (+1.35 %) |
| May 27 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Buy | M | 6.53 | 100,000 | 653,120 | 5,202,263 | 5.1 M to 5.2 M (+1.96 %) |
| May 27 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Buy | M | 14.00 | 60,000 | 840,000 | 5,102,263 | 5 M to 5.1 M (+1.19 %) |
| May 27 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Buy | M | 6.72 | 60,000 | 403,122 | 5,044,263 | 5 M to 5 M (+1.20 %) |
| May 20 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Grant | A | 0.00 | 25,000 | 0 | 4,982,263 | 5 M to 5 M (+0.50 %) |
| Apr 04 2005 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Gift | G | 0.00 | 7,000 | 0 | 4,957,263 | 5 M to 5 M (-0.14 %) |
| Nov 17 2004 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | Chief Executive Off ... | Option Exercise | A | 42.38 | 125,000 | 5,297,500 | 585,000 | |
| Jul 09 2004 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | Chief Executive Off ... | Gift | G | 0.00 | 22,000 | 0 | 4,964,263 | 5 M to 5 M (-0.44 %) |